Sign up to save your podcasts
Or
Share MDT discussions on the rationale for using GLP-1 as a therapeutic target in T2D
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
MDT discussions on the rationale for using GLP-1 as a therapeutic target in T2D
touchMDT for touchENDOCRINOLOGY
Listen to key experts from a multidisciplinary team review the rationale for using GLP-1 as a therapeutic target in T2D and provide an overview of GLP-1 RA based therapies
The multidisciplinary team
- Primary Care Physician: Dr Kevin Fernando, Berwick, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Novo Nordisk A/S. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchendocrinologyime.org/mdt-integrating-glp1ras-t2d-management-from-pcp-to-patient/
View all episodes
By touchpodcasttouchMDT for touchENDOCRINOLOGY
Listen to key experts from a multidisciplinary team review the rationale for using GLP-1 as a therapeutic target in T2D and provide an overview of GLP-1 RA based therapies
The multidisciplinary team
- Primary Care Physician: Dr Kevin Fernando, Berwick, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Novo Nordisk A/S. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchendocrinologyime.org/mdt-integrating-glp1ras-t2d-management-from-pcp-to-patient/